© 1993 Oxford University Press
RESEARCH-ARTICLE |
Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad
Abteilung Klinische Genetik der Universität D-89069 Ulm, , Germany 1Deutsches Krebsforschungszentrum D-69120 Herdelberg, Germany
*To whom correspondence should be addressed
Received July 26, 1993; Revised October 18, 1993; Accepted October 18, 1993
To elucidate the function of the FMR1 gene, we applied RNA in situ hybridization to cryosectlons of mice from different developmental stages. The murlne Fmr-1 was found transcribed in a ubiquitous manner with an expression pattern similar to glyceraldehyd phosphate dehydrogenase, Gapdh, which was used as a control gene. A significant difference in the Fmr-1 expression pattern, however, was markedly enhanced expression specifically confined to the testis and the fetal ovary. In the immature and mature testis an elevated level of Fmr-1 expression is found in type A1 spermatogonla. Expression in the testis is observed in fetal life, reaches the highest level in the immature testis, and declines early in adult life. In the mature ovary no specific Fmr-1 expression signal was found but enhanced levels were seen in the fetal ovary. At this developmental stage proliferation of oogonia takes place. It is suggested that FMR1 serves a special function during germ cell proliferation in males and females. These findings are discussed in the light of the current observation that fraglie X patients produce only sperm with a premutation sized allele. Two hypotheses are put forward: (1) In males lack of FMR1 function results in a premeiotic defect preventing spermatogonia with a full mutation to reach meiosis. A fragile X mutation can be passed on to offsprings only as a premutation (selection hypothesis). (2) Transition of a premutation alleie to full mutation occurs in a postzygotic stage after separation of the germ line and is restricted to soma cells (restriction hypothesis). Expression of FMR1 in proliferating germ cells is in line with both hypothesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  U. Zechner, J. Nolte, M. Wolf, K. Shirneshan, N. E. Hajj, D. Weise, B. Kaltwasser, A. Zovoilis, T. Haaf, and W. Engel Comparative methylation profiles and telomerase biology of mouse multipotent adult germline stem cells and embryonic stem cells Mol. Hum. Reprod., June 1, 2009; 15(6): 345 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.G. Allen, A.K. Sullivan, M. Marcus, C. Small, C. Dominguez, M.P. Epstein, K. Charen, W. He, K.C. Taylor, and S.L. Sherman Examination of reproductive aging milestones among women who carry the FMR1 premutation Hum. Reprod., August 1, 2007; 22(8): 2142 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Murdoch, G.-J. Feng, D. Bachner, L. Ormiston, J. H. White, D. Richter, and G. Milligan Periplakin Interferes with G Protein Activation by the Melanin-concentrating Hormone Receptor-1 by Binding to the Proximal Segment of the Receptor C-terminal Tail J. Biol. Chem., March 4, 2005; 280(9): 8208 - 8220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bardoni, M. Castets, M.-E. Huot, A. Schenck, S. Adinolfi, F. Corbin, A. Pastore, E. W. Khandjian, and J.-L. Mandel 82-FIP, a novel FMRP (Fragile X Mental Retardation Protein) interacting protein, shows a cell cycle-dependent intracellular localization Hum. Mol. Genet., July 15, 2003; 12(14): 1689 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Salat, B. Bardoni, D. Wöhrle, and P. Steinbach Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations? J. Med. Genet., November 1, 2000; 37(11): 842 - 850. [Abstract] [Full Text]
|
|
|
|
|
|
M. Wilda, I. Demuth, P. Concannon, K. Sperling, and H. Hameister Expression pattern of the Nijmegen breakage syndrome gene, Nbs1, during murine development Hum. Mol. Genet., July 22, 2000; 9(12): 1739 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Peier, K. L. McIlwain, A. Kenneson, S. T. Warren, R. Paylor, and D. L. Nelson (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features Hum. Mol. Genet., May 1, 2000; 9(8): 1145 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Liu, H. Siomi, M.C. Siomi, U. Fischer, Y. Zhang, L. Wan, and G. Dreyfuss Molecular Characterization of the Protein Products of the Fragile X Syndrome Gene and the Survival of Motor Neurons Gene Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 689 - 697. [Abstract] [PDF]
|
|
|
|
 |
|
 D. G. Monckton and C. T. Caskey Unstable Triplet Repeat Diseases Circulation, January 15, 1995; 91(2): 513 - 520. [Abstract] [Full Text]
|
|
|
|
|
|
D. Kumari and K. Usdin Interaction of the Transcription Factors USF1, USF2, and alpha -Pal/Nrf-1 with the FMR1 Promoter. IMPLICATIONS FOR FRAGILE X MENTAL RETARDATION SYNDROME J. Biol. Chem., February 2, 2001; 276(6): 4357 - 4364. [Abstract] [Full Text] [PDF]
|
|